In contrast, deletion or down-regulation of TRIM8 in hepatocytes led to a significant attenuation of insulin-resistant symptoms in HFD mice, and TRIM8 appeared to be a potent enhancer in the development of NASH (29). This evidence concerns the gene TRIM8 and metabolic dysfunction-associated steatohepatitis.